3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
10
Urinary Incontinence
2
Sexual Dysfunction, Physiological
2
Melanoma
2
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Secondary Malignant Neoplasm of Bone
1
Sarcoma
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Desmoid Tumors
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Interventions
nirogacestat
6
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
X-Rays
2
Toremifene
2
Phantoms, Imaging
2
Cryosurgery
2
Blood Specimen Collection
2
vactosertib
1
trifluridine tipiracil drug combination
1
strattice
1
liposomal doxorubicin
1
entinostat
1
anlotinib
1
Vinblastine
1
Taxes
1
Tamoxifen
1
Sunitinib
1
Sulindac
1
Sorafenib
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiofrequency Ablation
1
Oxaliplatin
1
Methotrexate
1
Leucovorin
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Desmoid Tumors
×
High-Intensity Focused Ultrasound Ablation
×
Clear all
NCT05111964
2026-02-04
SarcAblate
Oxford University Hospitals NHS Trust
Phase NA
Recruiting
10 enrolled